NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.
NexCure has raised $19.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
NexCure's investors include RA Capital Management, Oncology Ventures, Cencora Ventures.
NexCure is headquartered in Boston, United States.
NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.
NexCure is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NexCure — Funding & Investors." VCBacked, March 5, 2026, https://www.vcbacked.co/company/nexcure. Accessed October 23, 2026.
VCBacked. (2026). NexCure — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/nexcure
{{cite web |title=NexCure — Funding & Investors |url=https://www.vcbacked.co/company/nexcure |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated